|
TOP NEWS
EDITORIAL BOARDS
POLICY & REGULATION
Legislative Update: Cannabis And Psychedelics Bill Roundup
By Sam Reisman
State lawmakers in Delaware and West Virginia advanced legislation to more tightly regulate kratom products, Missouri and Kentucky legislators considered bills to fund research into the therapeutic uses of the psychedelic ibogaine, and Idaho's Legislature came together to urge voters to reject a medical marijuana legalization proposal that could be on the ballot this November. Here are the major moves in cannabis and psychedelics legislation from the past week.
Read full article »
| Save to favorites »
ENFORCEMENT & COMPLIANCE
LITIGATION
PEOPLE
EXPERT ANALYSIS
The Road Ahead For Drug Development In The US
Against the backdrop of drug manufacturers potentially looking to move development efforts overseas, the U.S. Food and Drug Administration's latest guidance on new approach methodologies signals the FDA is likely to be receptive to industry innovation that makes U.S.-based drug development faster or less expensive, creating opportunities and compliance risks for tech companies, say attorneys at Morgan Lewis.
Read full article »
| Save to favorites »
LEGAL INDUSTRY
|